Insights from 2023 ESMO Annual Meeting
ESMO 2023 Insights: "Efficacy & Safety From MANTRA Study - Milademetan vs. Trabectedin in Patients With Dedifferentiated Liposarcomas"
By
Insights from 2023 ESMO Annual Meeting
FEATURING
Robin Jones
By
Insights from 2023 ESMO Annual Meeting
FEATURING
Robin Jones
Comments 0
Login to view comments.
Click here to Login
